These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37537697)

  • 1. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses.
    Shi Y; Li H; Wu X; Li X; Yang M
    J Ovarian Res; 2023 Aug; 16(1):153. PubMed ID: 37537697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment.
    Wu M; Zhang M; Qu E; Sun X; Zhang R; Mu L; Xiao L; Wen H; Wang R; Liu T; Meng X; Wu S; Chen Y; Su M; Wang Y; Gu J; Zhang X
    Eur Radiol; 2024 Sep; 34(9):5978-5988. PubMed ID: 38374482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of contrast-enhanced ultrasound (CEUS) combined with Ovarian-Adnexal Reporting and Data System (O-RADS) ultrasound risk stratification for adnexal masses: a systematic review and meta-analysis.
    Yi YY; Li C; Zhu WJ; Hou YL
    Clin Radiol; 2024 Sep; 79(9):e1167-e1175. PubMed ID: 38942707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Contrast-Enhanced Ultrasound Parameters in the Evaluation of Adnexal Masses with Ovarian-Adnexal Reporting and Data System Ultrasound.
    Xu J; Huang Z; Zeng J; Zheng Z; Cao J; Su M; Zhang X
    Ultrasound Med Biol; 2023 Jul; 49(7):1527-1534. PubMed ID: 37032238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Benign From Malignant Ovarian Masses With Solid Components: Diagnostic Performance of CEUS Combined With IOTA Simple Rules and O-RADS.
    Lu B; He W; Liu C; Wang P; Yang P; Zhao Z; Qi J; Huang B
    Ultrasound Med Biol; 2024 Sep; 50(9):1449-1458. PubMed ID: 38876911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Contrast-enhanced US to O-RADS US for Classification of Adnexal Lesions with Solid Components: Time-intensity Curve Analysis versus Visual Assessment.
    Wu M; Wang Y; Su M; Wang R; Sun X; Zhang R; Mu L; Xiao L; Wen H; Liu T; Meng X; Huang L; Zhang X
    Radiol Imaging Cancer; 2024 Nov; 6(6):e240024. PubMed ID: 39392388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of contrast-enhanced ultrasound, IOTA simple rules and O-RADS for assessing the malignant risk of sonographically appearing solid ovarian masses.
    Lu B; Liu C; Qi J; He W; Shi T; Zhu Y; Huang B
    J Gynecol Obstet Hum Reprod; 2023 Apr; 52(4):102564. PubMed ID: 36868504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Study of the Efficacy of the Ovarian-Adnexa Reporting and Data System Ultrasound Combined With Contrast-Enhanced Ultrasound and the ADNEX MR Scoring System in the Diagnosis of Adnexal Masses.
    Wang T; Cui W; Nie F; Huang X; Huang L; Liu L; Zhu Y; Zheng R
    Ultrasound Med Biol; 2023 Sep; 49(9):2072-2080. PubMed ID: 37321953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study.
    Xu Y; Qi X; Zhao X; Ren W; Ding W
    Medicine (Baltimore); 2019 Jan; 98(4):e14051. PubMed ID: 30681562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.
    Yoeli-Bik R; Longman RE; Wroblewski K; Weigert M; Abramowicz JS; Lengyel E
    JAMA Netw Open; 2023 Jul; 6(7):e2323289. PubMed ID: 37440228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of ACR O-RADS combined with CA125 in the risk stratification of adnexal masses.
    Pan RK; Zhang SQ; Zhang XY; Xu T; Cui XW; Li R; Yu M; Zhang B
    Front Oncol; 2024; 14():1369900. PubMed ID: 39281376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessment.
    Zhu Q; Luo H; Middleton WD; Itani M; Hagemann IS; Hagemann AR; Hoegger MJ; Thaker PH; Kuroki LM; McCourt CK; Mutch DG; Powell MA; Siegel CL
    Ultrasound Obstet Gynecol; 2023 Dec; 62(6):891-903. PubMed ID: 37606287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive accuracy and reproducibility of the O-RADS US scoring system among sonologists with different training levels.
    Wu M; Zhang M; Cao J; Wu S; Chen Y; Luo L; Lin X; Su M; Zhang X
    Arch Gynecol Obstet; 2023 Aug; 308(2):631-637. PubMed ID: 35994107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic efficiency between the O-RADS US risk stratification system and doctors' subjective judgment.
    Zhou S; Guo Y; Wen L; Liu J; Fu Y; Xu F; Liu M; Zhao B
    BMC Med Imaging; 2023 Nov; 23(1):190. PubMed ID: 37986051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study.
    Amor F; Alcázar JL; Vaccaro H; León M; Iturra A
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):450-5. PubMed ID: 21465605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
    Yu MQ; Zhang LL; Jiang LP; Zhou AY
    Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Combing O-RADS US and CA-125 Improve Diagnostic Accuracy in Assessing Adnexal Malignancy Risk in Women With Different Menopausal Status?
    Wu M; Wang Q; Zhang M; Cao J; Chen Y; Zheng J; Luo L; Su M; Lin X; Kuang X; Zhang X
    J Ultrasound Med; 2023 Feb; 42(3):675-685. PubMed ID: 35880406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.